Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nitrofurantoin 100mg modified-release capsules
0501130R0AAAGAG
|
Nitrofurantoin | Nitrofurantoin | Infections | 586,155 |
|
Nitrofurantoin 50mg capsules
0501130R0AAAAAA
|
Nitrofurantoin | Nitrofurantoin | Infections | 52,282 |
|
Nitrofurantoin 50mg tablets
0501130R0AAADAD
|
Nitrofurantoin | Nitrofurantoin | Infections | 50,613 |
|
Nitrofurantoin 100mg tablets
0501130R0AAAEAE
|
Nitrofurantoin | Nitrofurantoin | Infections | 25,466 |
|
Nitrofurantoin 100mg capsules
0501130R0AAABAB
|
Nitrofurantoin | Nitrofurantoin | Infections | 19,117 |
|
Nitrofurantoin 25mg/5ml oral suspension sugar free
0501130R0AAACAC
|
Nitrofurantoin | Nitrofurantoin | Infections | 6,054 |
|
Macrobid 100mg modified-release capsules
0501130R0BGAAAG
|
Macrobid | Nitrofurantoin | Infections | 1,625 |
|
Nitrofurantoin 50mg/5ml oral liquid
0501130R0AAANAN
|
Nitrofurantoin | Nitrofurantoin | Infections | 99 |
|
Nitrofurantoin 25mg/5ml oral liquid
0501130R0AAAMAM
|
Nitrofurantoin | Nitrofurantoin | Infections | 62 |
|
Nitrofurantoin 50mg/5ml oral suspension sugar free
0501130R0AACMCM
|
Nitrofurantoin | Nitrofurantoin | Infections | 57 |
|
Genfura 100mg tablets
0501130R0BHAAAE
|
Genfura | Nitrofurantoin | Infections | 1 |
|
Genfura 50mg tablets
0501130R0BHABAD
|
Genfura | Nitrofurantoin | Infections | 1 |
|
Macrodantin 50mg capsules
0501130R0BCAAAA
|
Macrodantin | Nitrofurantoin | Infections | 1 |
|
Nitrofurantoin 12.5mg/5ml oral liquid
0501130R0AABEBE
|
Nitrofurantoin | Nitrofurantoin | Infections | 1 |
|
Nitrofurantoin 125mg/5ml oral liquid
0501130R0AABSBS
|
Nitrofurantoin | Nitrofurantoin | Infections | 1 |
|
Furadantin 100mg tablets
0501130R0BBABAE
|
Furadantin | Nitrofurantoin | Infections | No data available |
|
Furadantin 25mg/5ml oral suspension
0501130R0BBACAC
|
Furadantin | Nitrofurantoin | Infections | No data available |
|
Furadantin 50mg tablets
0501130R0BBAAAD
|
Furadantin | Nitrofurantoin | Infections | No data available |
|
Macrodantin 100mg capsules
0501130R0BCABAB
|
Macrodantin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 100mg/5ml oral liquid
0501130R0AAAJAJ
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 10mg/5ml oral liquid
0501130R0AAATAT
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 11mg/5ml oral liquid
0501130R0AACGCG
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 12mg/5ml oral liquid
0501130R0AAAUAU
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 13.5mg/5ml oral liquid
0501130R0AACECE
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 13mg/5ml oral liquid
0501130R0AAASAS
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.